Clinical effects of switching from minodronate to denosumab treatment in patients with postmenopausal osteoporosis: a retrospective study

BACKGROUND: Denosumab is a major treatment option for patients with postmenopausal osteoporosis; however, the evidence for its use is lacking. Therefore, in this 24-month retrospective study, we aimed to evaluate the effects of switching from minodronate (MIN) to denosumab in these patients. METHODS...

Descripción completa

Detalles Bibliográficos
Autores principales: Kobayashi, Masaki, Sawada, Kenjiro, Yoshimura, Akihiko, Yamamoto, Misa, Shimizu, Aasa, Shimura, Kotaro, Komura, Naoko, Miyamoto, Mayuko, Ishida, Kyoso, Kimura, Tadashi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7057589/
https://www.ncbi.nlm.nih.gov/pubmed/32138724
http://dx.doi.org/10.1186/s12905-020-00913-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7057589/
https://www.ncbi.nlm.nih.gov/pubmed/32138724
http://dx.doi.org/10.1186/s12905-020-00913-x

Ejemplares similares